ACADIA Pharmaceuticals Inc. technical analysis
Technical analysis of ACADIA Pharmaceuticals Inc. (stock) with the Montbon Method — Elliott Waves, moving averages and a 0–100 score.
What is ACADIA Pharmaceuticals Inc.
ACADIA Pharmaceuticals Inc. (ACAD) is a biopharmaceutical company focused on the development and commercialization of medicines for neurological and rare diseases in North America. Its marketed products include NUPLAZID (pimavanserin) for Parkinson's disease psychosis and DAYBUE (trofinetide) for the treatment of Rett syndrome. The company also has several candidates in clinical development for indications such as Alzheimer's disease psychosis, major depressive disorder, and essential tremor.
Description generated automatically from public sources; it may be inaccurate or out of date.
ACADIA Pharmaceuticals Inc.: latest session data
Closing values for October 20, 2026, computed on the last 12 months of prices.
Moving averages
21 sessions
20.51 $
−0.33%
50 sessions
25.18 $
−18.83%
200 sessions
23.94 $
−14.63%
Session levels
s2
18.85
Support
s1
19.33
Support
pivot
19.58
Pivot
r1
20.06
Resistance
r2
20.31
Resistance
How to read it
In the October 20, 2026 session ACADIA Pharmaceuticals Inc. closed higher at 20.44 $, +3.23% versus the previous session.
The price sits below every moving average observed: −0.33% against the 21-session average, −18.83% against the 50 and −14.63% against the 200.
The 14-period RSI reads 40.3, in neutral territory.
MACD stands at -1.569 against a signal line at -1.852: the histogram is positive (+0.283).
ADX reads 51.0, indicating a marked directionality.
Levels computed on the latest session place supports at 19.33 and 18.85 $ and resistances at 20.06 and 20.31 $, around a pivot of 19.58.
The average daily range (ATR) is 0.795 $, or 3.89% of price.
Turnover was 1.7M shares, 71% of the 20-session average.
Over the last twelve months the price ranged between 18.39 and 30.96 $, and today stands −33.98% from the period high.
Measures computed on closing prices. They describe the past; they are not forecasts.
Score, Elliott Waves, moving averages and technical indicators — free, no card
If you're not registered we'll ask you to sign in (free), then open the ACAD analysis.
How Montbon’s technical analysis works
Montbon analyses markets with Elliott Waves, multi-timeframe moving averages and a 0–100 score summarising the technical setup. It is an informational screening tool.
Elliott Waves
Wave counting to frame the price structure.
MTF moving averages
Moving averages across timeframes to read the trend.
0–100 score
A technical summary of the setup, updated daily.
FAQ about ACADIA Pharmaceuticals Inc.
What technical indicators are commonly used to analyze a stock like ACAD?
For a healthcare sector stock like ACAD, analysts often use momentum indicators such as RSI and MACD, moving averages to identify the underlying trend, and Bollinger Bands to measure volatility. These tools help contextualize price movements independently of company fundamentals.
On which timeframes is it useful to observe the technical analysis of ACAD?
Technical analysis of ACAD can be conducted across different timeframes: daily and weekly charts are often used to identify medium-to-long-term trends, while 15-minute or 60-minute charts may be used for a closer observation of shorter-term price fluctuations.
What are Elliott Waves and how do they apply to a stock like ACAD?
Elliott Wave Theory is a technical analysis method that proposes prices move in repetitive sequences of impulsive and corrective waves. Applied to ACAD, it involves searching for recurring structures in the price chart, though its interpretation requires experience and may differ among analysts.
Other tickers to analyse
Disclaimer. For informational purposes only; not financial advice or a recommendation. Montbon Analytics is not an authorised financial intermediary.
Are you an issuer and want a correction or removal? Write to info@montbon.com.